porcine pancreatic islets

Porcine pancreatic islets are clusters of insulin-producing endocrine cells isolated from the pancreas of pigs. They are being developed as a cell therapy for type 1 diabetes and other forms of insulin-dependent diabetes, particularly in cases where human donor islets are unavailable or insufficient. The primary mechanism involves the transplantation of these functional pig-derived islet cells into diabetic patients to restore endogenous insulin production and regulate blood glucose levels. Porcine islet xenotransplantation aims to provide a renewable source of high-quality insulin-secreting cells, potentially reducing or eliminating dependence on exogenous insulin injections and preventing diabetes-related complications. Key challenges include immune rejection (necessitating immunosuppression or encapsulation technologies), risk of xenoantigen-mediated responses, and ensuring long-term graft survival and function[1][2][3][4].

Other names

pig pancreatic isletsporcine islet cellsporcine islet xenograft